159 related articles for article (PubMed ID: 36560396)
1. A Novel Finding of an HLA Allele's and a Haplotype's Relationship with SARS-CoV-2 Vaccine-Associated Subacute Thyroiditis.
Sahin Tekin M; Yorulmaz G; Yantir E; Gunduz E; Colak E
Vaccines (Basel); 2022 Nov; 10(12):. PubMed ID: 36560396
[TBL] [Abstract][Full Text] [Related]
2. Association of Human Leukocyte Antigen Genotypes with Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine-Induced Subacute Thyroiditis.
Şendur SN; Özmen F; Oğuz SH; İremli BG; Malkan ÜY; Gürlek A; Erbas T; Ünlütürk U
Thyroid; 2022 Jun; 32(6):640-647. PubMed ID: 35387473
[No Abstract] [Full Text] [Related]
3. HLA typing of patients who developed subacute thyroiditis and Graves' disease after SARS-CoV-2 vaccination: a case report.
Yasuda S; Suzuki S; Yanagisawa S; Morita H; Haisa A; Satomura A; Nakajima R; Oikawa Y; Inoue I; Shimada A
BMC Endocr Disord; 2023 Mar; 23(1):54. PubMed ID: 36879263
[TBL] [Abstract][Full Text] [Related]
4. Clinical Manifestation of Subacute Thyroiditis Triggered by SARS-CoV-2 Infection Can Be HLA-Dependent.
Stasiak M; Zawadzka-Starczewska K; Lewiński A
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960716
[TBL] [Abstract][Full Text] [Related]
5. Significance of HLA Haplotypes in Two Patients with Subacute Thyroiditis Triggered by mRNA-Based COVID-19 Vaccine.
Stasiak M; Zawadzka-Starczewska K; Lewiński A
Vaccines (Basel); 2022 Feb; 10(2):. PubMed ID: 35214738
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Vaccine-induced Thyroiditis: Safety of Revaccinations and Clinical Follow-up.
Oğuz SH; Şendur SN; İremli BG; Gürlek A; Erbas T; Ünlütürk U
J Clin Endocrinol Metab; 2022 Apr; 107(5):e1823-e1834. PubMed ID: 35100622
[TBL] [Abstract][Full Text] [Related]
7. The New Entity of Subacute Thyroiditis amid the COVID-19 Pandemic: From Infection to Vaccine.
Popescu M; Ghemigian A; Vasile CM; Costache A; Carsote M; Ghenea AE
Diagnostics (Basel); 2022 Apr; 12(4):. PubMed ID: 35454008
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 vaccine-associated subacute thyroiditis: insights from a systematic review.
Ippolito S; Gallo D; Rossini A; Patera B; Lanzo N; Fazzino GFM; Piantanida E; Tanda ML
J Endocrinol Invest; 2022 Jun; 45(6):1189-1200. PubMed ID: 35094372
[TBL] [Abstract][Full Text] [Related]
9. SARS-COV-2 specific t-cells in patients with thyroid disorders related to COVID-19 are enriched in the thyroid and acquire a tissue-resident memory phenotype.
Silvestri Y; Clemente F; Moschetti G; Maioli S; Carelli E; Espadas de Arias A; Torelli R; Longhi E; De Feo T; Crosti M; Sarnicola ML; Salvi M; Mantovani G; Arosio M; Bombaci M; Pesce E; Grifantini R; Abrignani S; Geginat J; Muller I
Clin Immunol; 2023 Sep; 254():109684. PubMed ID: 37451415
[TBL] [Abstract][Full Text] [Related]
10. Vaccine-Induced Subacute Thyroiditis (De Quervain's) after mRNA Vaccine against SARS-CoV-2: A Case Report and Systematic Review.
Pipitone G; Rindi LV; Petrosillo N; Foti NAM; Caci G; Iaria C; Donno DR; Boumis E; Paviglianiti G; Taglietti F
Infect Dis Rep; 2022 Feb; 14(1):142-154. PubMed ID: 35200445
[TBL] [Abstract][Full Text] [Related]
11. Subacute thyroiditis during the COVID-19 pandemic: a prospective study.
Bahçecioğlu AB; Karahan ZC; Aydoğan BI; Kalkan IA; Azap A; Erdoğan MF
J Endocrinol Invest; 2022 Apr; 45(4):865-874. PubMed ID: 35023078
[TBL] [Abstract][Full Text] [Related]
12. Subacute Thyroiditis Following SARS-CoV-2 Vaccines: Six Cases Report and Review of the Literature.
Kurtulmus N; Kayikci K
Horm Metab Res; 2022 Aug; 54(8):556-561. PubMed ID: 35318621
[TBL] [Abstract][Full Text] [Related]
13. Subacute Thyroiditis is Associated with
Stasiak M; Tymoniuk B; Michalak R; Stasiak B; Kowalski ML; Lewiński A
J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32079059
[TBL] [Abstract][Full Text] [Related]
14. Is Subacute Thyroiditis an Underestimated Manifestation of SARS-CoV-2 Infection? Insights From a Case Series.
Brancatella A; Ricci D; Cappellani D; Viola N; Sgrò D; Santini F; Latrofa F
J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32780854
[TBL] [Abstract][Full Text] [Related]
15. Successful Management of Subacute Thyroiditis Following SARS-CoV-2 Infection.
Sato D; Nishiguchi S; Tanaka E
Intern Med; 2021 Nov; 60(22):3573-3576. PubMed ID: 34511569
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 vaccine-associated subacute thyroiditis.
Yorulmaz G; Sahin Tekin M
J Endocrinol Invest; 2022 Jul; 45(7):1341-1347. PubMed ID: 35182366
[TBL] [Abstract][Full Text] [Related]
17. New aspects in the pathogenesis and management of subacute thyroiditis.
Stasiak M; Lewiński A
Rev Endocr Metab Disord; 2021 Dec; 22(4):1027-1039. PubMed ID: 33950404
[TBL] [Abstract][Full Text] [Related]
18. Clinical, biochemical features and functional outcome of patients with SARS-CoV-2-related subacute thyroiditis: a review.
Viola N; Brancatella A; Sgrò D; Santini F; Latrofa F
Endocrine; 2023 Mar; 79(3):448-454. PubMed ID: 36394704
[TBL] [Abstract][Full Text] [Related]
19. Insights into SARS-CoV-2-associated subacute thyroiditis: from infection to vaccine.
Ziaka M; Exadaktylos A
Virol J; 2023 Jun; 20(1):132. PubMed ID: 37344878
[TBL] [Abstract][Full Text] [Related]
20. Case report: subacute thyroiditis after receiving SARS-CoV-2 vaccine, maybe not only adjuvants.
Huang Y; Chen X; Wang Q; Lei X; Zhang L
Front Med (Lausanne); 2022; 9():856572. PubMed ID: 35991637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
